114 related articles for article (PubMed ID: 4216125)
1. Radiotherapy combined with hormone therapy for prostate cancer.
Tsuya A; Kawai T; Fukushima S; Shida K; Shimazaki J
Strahlentherapie; 1974 Jul; 148(1):24-34. PubMed ID: 4216125
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study on adenocarcinoma of the prostate].
Yamamoto A; Yuasa M; Imagawa A; Kagawa S; Kurokawa K
Hinyokika Kiyo; 1987 Dec; 33(12):2050-4. PubMed ID: 3448932
[TBL] [Abstract][Full Text] [Related]
3. [Update of experience with prostatic cancer].
Nitecki S; Kuten A; Cohen Y
Harefuah; 1993 Mar; 124(5):261-5, 320, 319. PubMed ID: 8495915
[TBL] [Abstract][Full Text] [Related]
4. [Five-year trend in new patients with prostatic carcinoma].
Moriyama N; Akaza H; Sugimoto M; Taniguci J; Hara M; Fukutani K; Kitamura T; Higashihara E; Kishi H; Umeda T
Hinyokika Kiyo; 1988 Jun; 34(6):997-1001. PubMed ID: 3066215
[TBL] [Abstract][Full Text] [Related]
5. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
[TBL] [Abstract][Full Text] [Related]
6. [Combination therapy with hormonal, radiation and chemotherapy for stage C prostate cancer].
Iwasawa T; Matsumoto H
Hinyokika Kiyo; 1996 Nov; 42(11):869-74. PubMed ID: 8973937
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of 169 patients with prostate cancer].
Okaneya T; Mizusawa H; Yoneyama T; Taguchi I; Komiyama I; Kawakami M; Hosaka K; Tsuruta T; Murata Y; Komatsu H; Misawa K; Kiyokawa H
Hinyokika Kiyo; 1996 Aug; 42(8):563-7. PubMed ID: 8889563
[TBL] [Abstract][Full Text] [Related]
8. Continuous course of megavoltage radiotherapy for carcinoma of the prostate.
Weshler Z; Gez E; Pfeffer MR; Ben-Yosef R; Loeventhal E; Fuks Z
Isr J Med Sci; 1988; 24(9-10):580-3. PubMed ID: 3144515
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of prostate cancer--statistical analysis in the last 10 years].
Yamamoto N; Shimabukuro T; Matsuyama H; Yoshihiro S; Mitsui H; Sakatoku J
Hinyokika Kiyo; 1991 Jul; 37(7):705-10. PubMed ID: 1927770
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study of prostate cancer: statistical analysis of 107 cases in the past 12 years].
Umeda Y; Hayashi N; Ogawa K; Kuromatsu I; Franco OE; Su J; Yamakawa K; Arima K; Yanagawa M; Kawamura J
Hinyokika Kiyo; 2000 Dec; 46(12):873-8. PubMed ID: 11211803
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of prostatic cancer--statistical analysis of 184 cases in the latest 21 years].
Yamashita A; Hayashi N; Sugimura Y; Yanagawa M; Arima K; Nakano S; Kimbara H; Tochigi H; Kawamura J
Hinyokika Kiyo; 1995 Jun; 41(6):447-53. PubMed ID: 7645452
[TBL] [Abstract][Full Text] [Related]
13. [A multimodal treatment of prostatic carcinoma and the 5-year survival rate].
Maruoka M; Miyauchi T; Nagayama T
Hinyokika Kiyo; 1989 Jan; 35(1):57-63. PubMed ID: 2729020
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of 683 prostatic cancer patients in the Tokai Urological Cancer Registry].
Obata JK; Kuriyama M; Fujita K; Sakai S; Okishio N; Sakagami H; Higashino I; Miyake K
Hinyokika Kiyo; 1996 Jul; 42(7):503-7. PubMed ID: 8809558
[TBL] [Abstract][Full Text] [Related]
15. [Fast neutron radiotherapy of prostate cancer].
Morita S; Tsunemoto H; Akimoto S; Fuse H; Shimazaki J; Fukushima G; Kitagawa R
Gan No Rinsho; 1989 Feb; 35(3):378-84. PubMed ID: 2926986
[TBL] [Abstract][Full Text] [Related]
16. [Course of prostate cancer under estrogen therapy].
Ducassou J; Richaud C; Hermanowicz M; Fiquet JM; Alimi JC
J Urol Nephrol (Paris); 1977; 83(1-2):91-9. PubMed ID: 875131
[TBL] [Abstract][Full Text] [Related]
17. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
[TBL] [Abstract][Full Text] [Related]
18. [Combination therapy with estrogen and UFT in newly diagnosed prostatic cancer (poorly differentiated, stage D2)].
Kondo I; Miura T; Fujii H; Harada M; Fukushima S; Kubota Y; Hosaka M
Hinyokika Kiyo; 1996 Mar; 42(3):201-6. PubMed ID: 8619389
[TBL] [Abstract][Full Text] [Related]
19. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]